Skip to content
NBDC Human Database

No datasets in the cart.

Due to system maintenance, the application system, application review by the Data Access Committee will be unavailable during the following period.
Schedule: October 5th (Mon), 2026, 9:00 - October 7th (Wed), 2026, 15:00 (JST)
We apologize for any inconvenience this may cause and appreciate your understanding.

We are currently receiving a large number of applications for data submission, and the review process is taking longer than usual.We sincerely apologize for the delay and kindly ask for your understanding. When submitting an application, we would greatly appreciate it if you could allow sufficient time for the processing.

Following a change to our organizational structure effective April 1, 2026, this division has been renamed from the "Database Center for Life Science, Joint Support-Center for Data Science Research" to the "Database Division for Life Science (DBCLS), BioData Science Initiative (BSI), National Institute of Genetics (NIG)". Where the former name still appears in the guidelines, please read it as the new name.

Dataset ID

JGAD000907

Type of data
NGS (RNA-seq, scRNA-seq, scTCR-seq, Exome)
Access criteria
Controlled-access (Type I)
Total data volume
217 GB
File formats
  • FASTQ
Research
hum0268
Date published
2025-08-29
Date modified
2025-12-11

Analysis method

RNA-seq

Materials and participants
Human colon cancer cell line (ICD10: C18): 1 sample
Colon cancer: 6 patients
(6 tumor tissues and 5 non-tumor tissues)
Endometrial cancer (ICD10: C54.9): 5 patients (5 tumor tissues)
  • Health status
    Affected
  • Subject count
    11 (Individual)
Disease
Human colon cancer cell line (C18)
Endometrial cancer (C549)
Sample description
RNAs extracted from cells
  • Tumor / normal
    Mixed
Cell line
COLO 320DM
Sample provider
ATCC (CCL-220)
Experimental method
RNA-seq
Target
N/A
Reagent kit
TruSeq Stranded mRNA Library Prep Kit
Fragmentation
included in the above library construction kit
Platform
Illumina NovaSeq 6000
Read type
Paired-end
Read length
100 bp

scRNA-seq

Materials and participants
Endometrial cancer (ICD10: C54.9): 1 patient
(tumor-infiltrating T cells from 1 tumor tissue: 1 sample)
  • Health status
    Affected
  • Subject count
    1 (Individual)
Disease
Endometrial cancer (C549)
Sample description
RNAs extracted from tumor-infiltrating T cells
  • Tissue
    TIL
  • Tumor / normal
    Tumor
Sample provider
N/A
Experimental method
scRNA-seq
Target
N/A
Reagent kit
Chromium Next GEM Single Cell V(D)J v1.1
Fragmentation
included in the above library construction kit
Platform
MGI DNBSEQ
Read type
Paired-end
Read length
91 bp

scTCR-seq

Materials and participants
Endometrial cancer (ICD10: C54.9): 1 patient
(tumor-infiltrating T cells from 1 tumor tissue: 1 sample)
  • Health status
    Affected
  • Subject count
    1 (Individual)
Disease
Endometrial cancer (C549)
Sample description
RNAs extracted from tumor-infiltrating T cells
  • Tissue
    TIL
  • Tumor / normal
    Tumor
Sample provider
N/A
Experimental method
TCR-seq
Target
N/A
Reagent kit
Chromium Next GEM Single Cell V(D)J v1.1
Fragmentation
included in the above library construction kit
Platform
MGI DNBSEQ
Read type
Paired-end
Read length
91 bp

WES

Materials and participants
Endometrial cancer (ICD10: C54.9): 5 patients
(5 tumor tissues, 5 peripheral blood cells)
  • Health status
    Affected
  • Subject count
    5 (Individual)
Disease
Endometrial cancer (C549)
Sample description
DNAs extracted from tumor tissues and peripheral blood cells
  • Tissue
    Peripheral blood
  • Tumor / normal
    Mixed
Sample provider
N/A
Experimental method
WES
Target
N/A
Reagent kit
SureSelect Human All Exon V6
Fragmentation
included in the above library construction kit
Platform
Illumina NovaSeq 6000
Read type
Paired-end
Read length
150 bp